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Delayed primacy performance, but not delayed nonprimacy performance, has been shown to be asso-
ciated with hippocampal volume in cognitively intact older individuals. Because presence of neuro-
fibrillary tangles is an early sign of AD-related pathology, we set out to test whether cerebrospinal
fluid (CSF) levels of tau had an effect on delayed primacy performance, while controlling for hippo-
campal volume and CSF amyloid-b 1-42 levels.
Methods: Forty-seven individuals, aged 60 years or older and cognitively intact, underwent a multi-
session study including lumbar puncture, a magnetic resonance imaging (MRI) scan of the head, and
memory testing.
Results: Our regression analyses show that CSF levels of hyperphosphorylated (P) tau are only asso-
ciated with reduced delayed primacy performance when hippocampal volumes are smaller.
Conclusion: Our findings suggest that hippocampal size may play a protective role against the nega-
tive effects of P tau on memory.
 2015 The Authors. Published by Elsevier Inc. on behalf of the Alzheimer’s Association. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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The identification of individuals at risk of Alzheimer’s
disease (AD) during preclinical stages is critical for the im-
plementation of early intervention strategies [1]. Recently,
episodic memory performance for primacy items (i.e., firstthor. Tel.: 144-(0)151-2913832.
unod@hope.ac.uk
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commons.org/licenses/by-nc-nd/4.0/).few items on a study list) has been shown to provide predic-
tive value for cognitive decline in both cognitively intact
elderly [2] and conversion from mild cognitive impairment
(MCI) to AD [3]. Primacy performance, especially in de-
layed memory tasks (e.g., after 20 minutes), is thought to
reflect consolidation ability [4], a critical target function
for prediction of subsequent neurodegeneration [5]. Impor-
tantly, consolidation is thought to rely on the hippocampal
formation [6], whose integrity has also been examined in
studies of AD prediction (e.g., [7–9]). Finally, we haveimer’s Association. This is an open access article under the CC BY-NC-ND
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primacy performance, but not memory performance for other
regions of the study list, in cognitively intact older
individuals, thus confirming the link between hippocampus
and memory for early list items [10].
A key component of AD neuropathology is the presence
of neurofibrillary tangles, which are typically observed in
the medial temporal lobe (MTL) first, and in the hippocam-
pus in particular [11]. The degree of neurofibrillary tangle
burden has been associated with levels of total (T) and hy-
perphosphorylated (P) tau in clinical-postmortem compari-
son studies ([12–14] but see [15]), suggesting that in vivo
cerebrospinal fluid (CSF) levels of T and P tau may serve
as surrogate measures for the degree of hippocampal and
cortical neurofibrillary pathology. CSF levels of T and P
tau have been found to associate with short-term memory
performance in AD [16] and to correlate negatively with hip-
pocampal volume both in individuals with AD [17] and MCI
[18]. Moreover, P tau is considered a key factor in entorhinal
cortex degeneration in cognitively intact participants [19].
For the reasons mentioned previously, we set out to test
whether delayed primacy performance—defined as the first
four words on the study list to maintain consistency with
[2]—in cognitively intact individuals is associated with CSF
levels of Tand P tau. In particular, we expect that higher levels
of P tau, which may reflect tangle pathology [20] affecting the
hippocampus and cortical brain areas, will be associated with
poorer primacy performance. Moreover, we explore whether
the relationship between hippocampal size and delayed pri-
macy performance [10] is moderated by CSF tau levels, while
controlling also for CSF levels of amyloid-b (Ab) 1-42, which
provide an index of amyloid pathology (e.g., [14]).2. Methods
2.1. Subjects
Participants for the study were recruited from either the
Memory Education and Research Initiative (MERI) program
at the Nathan Kline Institute for Psychiatric Research (NKI)
or via advertisements; recruitment was originally for a study
on major depression disorder (MDD) in old age (see [21]).
The study was approved by the institutional review boards
of the NKI and the New York University (NYU) School of
Medicine. All participants were paid up to $450.00 for their
participation in the study and provided formal consent before
testing. A total of 133 participants were recruited for the
study, although only 51 received a lumbar puncture from
which CSF could be extracted. To maintain a cognitively
intact sample, we excluded participants whose Mini-Mental
State Examination (MMSE) score was below 28 and/or pre-
sented magnetic resonance imaging (MRI) evidence of
confluent deep or periventricular white matter hyperinten-
sities. These exclusion criteria left us with a total of 47 partic-
ipants, 28 of whom received a diagnosis of MDD from a
board-certified psychiatrist (N.P.) and 19 were controls.2.2. CSF measurements
Ab1-42 CSF levels were analyzed with electrochemilumi-
nescence technology using the MS6000 Human Ab Ultra-
Sensitive Kit (Meso Scale Discovery, Gaithersburg, MD,
USA). Both T and P tau concentrations were determined us-
ing a sandwich ELISA (Innotest hTAU-Ag, Innogenetics,
Ghent, Belgium) specifically constructed for all tau iso-
forms, irrespective of phosphorylation status.
2.3. MRI acquisition
The acquisition was performed on a 1.5-T Siemens
Vision system (Erlangen, Germany) at the NKI. Images
were acquired using a sagittal magnetization prepared rapid
gradient-echo sequence (repetition time [TR]/echo time
[TE] 5 11.4/11.9 ms, 1 excitation [NEX], matrix 5 256
! 256, field of view [FOV] 5 307 mm, 1.2 mm3 isotropic
voxel, 172 slices, no gap). Evaluation of white matter hyper-
intensities was performed using a fluid-attenuated inversion
recovery sequence (TR/TE 5 9000/119 ms, inversion
time 5 2400 ms, NEX 5 1, matrix 256 ! 256,
FOV 5 240 mm, slice thickness 5 4 mm, 1 mm gap).
2.4. MRI preprocessing and analysis
MRI data processing followed procedures described pre-
viously [22,23]. Fig. 1 illustrates the hippocampal regions of
interest. The total intracranial volume (TIV) was used in the
statistical model to account for differences in head size (see
Study design and analysis below) and was calculated as the
sum of the total segmented gray matter, white matter, and
CSF volumes in native space.
2.5. Procedure
The study was conducted at the NKI and at the Clinical
and Translational Science Institute, NYU, over multiple
visits. On the first visit, after informed consent was provided,
volunteers were administered a general medical intake ques-
tionnaire and had their vital signs measured; the MMSE
score and the Hamilton Depression Rating (HAM-D) score,
which measures severity of current depressive symptoms,
were obtained during this visit. On a second visit, partici-
pants received anMRI scan of the head. Neuropsychological
testing took place on a third visit, and memory performance
was assessed at this stage with the Buschke Selective Re-
minding Test (BSRT) [24]. This test comprises a list of 16
unrelated nouns, presented orally to the participant at a
rate of 2 seconds each. After presentation, participants
were asked to freely recall as many items as possible, stop-
ping once they feel no more items can be retrieved. In the
delayed trial, which is the focus of our current examination
(cf., 2), the free recall task occurs roughly after a 20-minute
delay from the initial presentation.
During a fourth and final session, a lumbar puncture was
performed under guided fluoroscopy. Participants were
Fig. 1. Hippocampal regions of interest in Montreal Neurological Institute space.
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tween 9 AM and 10 AM in the morning. A total of 15 mL
of clear CSF was collected in three polypropylene tubes
labeled “A” (first 5 mL), “B” (second 5 mL), and “C”
(third 5 mL). The tubes were immediately placed on ice
for a maximum of 1 hour until the samples were centri-
fuged at 4C (at 1500 rpm) for 10 minutes. Aliquots of
0.25 mL were subsequently placed into 1-mL polypro-
pylene cryogenic vials and put into Nunc eight-cell storage
boxes (Nalge Nunc International, Rochester, NY, USA) at
280C. All Ab and tau determinations were performed
from tube C.2.6. Study design and analysis
To test our hypothesis that P tau, either directly or via
moderation with hippocampal gray matter volume, predicts
delayed primacy performance, we carried out multiple
linear regression analyses. The outcome variables,
analyzed separately, were (1) the proportion of primacy
items (first four words; cf. [2]) recalled in the delayed
task of the BSRT task and (2) the proportion of nonprimacy
(all words recalled minus primacy words) items recalled inthe same task. Both outcome variables were normally
distributed based on assessment of skewness and kurtosis
[25]. The main predictor was CSF tau, either T or P in
separate analyses to avoid multicollinearity (the correlation
between T and P tau yielded an r coefficient of 0.968,
P , .001). Moreover, we also tested the tau (both T and
P) by hippocampal volume moderation term in a separate
model. Age, CSF Ab1-42, total hippocampal volume
(mm3), TIV (mm3) to control for head size, and HAM-D
score to control for presence of current depressive symp-
toms were used as control variables in a three-model pro-
cedure. Model 1 included all control variables, model 2
included the predictor, and model 3 included the modera-
tion term. Finally, all predictors and control variables
were standardized.3. Results
Table 1 reports group demographics, CSF values, and
memory performance scores. The total N for T tau was 46
because of a missing value. No issues of multicollinearity
were observed (variance inflation factor 2.628) in the
regression analyses. Considering the mixed nature of our
Table 1
Demographics, CSF values, and memory performance: age in years (mean
and standard deviation); HDS score (mean and standard deviation); CSF
levels of Ab1-42, T and P tau (mean and standard deviation); and proportions
of primacy and nonprimacy performance (mean and standard deviation)
Variable Mean (SD)
Age 67.13 (6.23)
HDS 10.55 (11.01)
Ab1-42 269.45 (158.93)
T tau 296.02 (132.38)*
P tau 50.00 (23.78)
Primacy 0.64 (0.27)
Nonprimacy 0.54 (0.17)
Abbreviations: CSF, cerebrospinal fluid; HDS, Hamilton Depression Rat-
ing score; Ab, amyloid-b.
NOTE. Number of subjects (i.e., N) for each measurement was 47 except
stated otherwise.
*Because of an undetermined value, the N for T tau is 46.
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ated the possibility that the HAM-D scores could be highly
skewed (e.g., 0 values for all controls). However, visual
exploration of the scores yielded no significant outliers,
and z scores for both skewness and kurtosis were within
the typically accepted 1.96 threshold (1.80; 25).
P tau was a significant predictor of delayed primacy per-
formance (b 5 20.388, P 5 .022), but this relationship ap-
pears to be qualified by the interaction between P tau and
hippocampal size (b 5 0.354, P 5 .035). The interaction
brought explained variance (R2) from 0.191 with model 1
and 2 combined to 0.280 with model 3, for a 32% increase.
Fig. 2 shows that delayed primacy performance is unaffected
by changes in P tau CSF levels at larger hippocampal vol-
umes but declines when the P tau levels are higher and the
size of the hippocampus is smaller. These results suggest
that hippocampal size may provide a form of protection
against increases in P tau CSF levels.
In contrast, neither P tau (only 0.009 variance explained
over model 1), nor the moderation term (only 0.001 vari-
ance explained over model 2), nor any of the control vari-
ables appeared to predict delayed nonprimacy performance
significantly. The closest predictor in this analysis was0
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Fig. 2. Plot of cerebrospinal fluid P tau levels (x-axis) by proportion of de-
layed recalled primacy items (y-axis), as moderated by hippocampal gray
matter volume.Ab1-42 (b 5 0.280, P 5 .090), suggesting that higher levels
of CSF Ab1-42, which should index less amyloid pathology,
may be associated with better memory performance for
nonprimacy items.
Analogously to P tau, T tau showed marginal effects on
delayed primacy both independently (b 5 20.336,
P 5 .078) and as part of the interaction (b 5 0.315,
P 5 .072), although neither relationship is statistically sig-
nificant. Also, once again, the closest significant predictor
of nonprimacy performance was CSF Ab1-42 (b 5 0.279,
P 5 .095).4. Discussion
Recent findings have shown that delayed free recall perfor-
mance for early list words (i.e., delayed primacy perfor-
mance) may be predictive of cognitive decline in older
individuals who are cognitively intact at baseline [2] and
that, also in cognitively healthy participants, hippocampal
gray matter volume is associated with delayed primacy, but
not delayed nonprimacy, performance [10]. These results
are consistent with a burgeoning literature on the predictive
and diagnostic value of serial position analysis, and primacy
in particular (e.g., [3,26,27]). In this study on cognitively
intact elderly individuals, we have demonstrated for the first
time that delayed primacy performance is also affected by
CSF levels of P tau. P tau is a marker of neurofibrillary
pathology, which is considered to be one of the first
neuropathological events in AD, and is thought to be
initiated in the MTL, including the hippocampus. Critically,
we observed in our study an interaction effect between
hippocampal gray volume and CSF P tau levels on delayed
primacy performance. This interaction suggests that
hippocampal size may act as a protective factor against the
deleterious effects of P tau on delayed primacy performance.
A limitation of our present study is that the sample was
made up of both participants with a diagnosis of MDD and
healthy controls. MDD has been associated with poorer
memory performance (e.g., [28]) and reduced hippocampal
volume (e.g., [29]), and it is therefore possible that the com-
bination of healthy and depressed participants may have
confounded our results. However, considering that we
controlled for the HAM-D score in all of our analyses, we
feel quite confident that depressive symptoms did not signif-
icantly alter the pattern of our results.
Another potential issue pertains to the possibility of a se-
lection bias in CSF collection. As noted, of 133 total partic-
ipants, only 51 subjects consented to the lumbar puncture.
The idea of having a lumbar puncture can be frightening,
and all prospective participants were informed of the
possible side effects, such as bleeding and headaches. There-
fore, it is not implausible that a systematic bias may be intro-
duced in the study and that only certain participants (e.g.,
only highly motivated participants, or highly educated)
may have consented to the lumbar puncture. However, a
basic comparison between consenters and nonconsenters,
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MMSE score, or years of education (P  .208), provides
no evidence of a bias, although this possibility cannot be
categorically ruled out.
Attempts at investigating the relationship between hippo-
campal volume and episodicmemory function in older adults
have been met so far with high levels of variability across
studies and little supporting evidence of a positive correlation
between size and performance [30]. Our results may help
clarifying this issue. First of all, if the hippocampus is primar-
ily involved with the retrieval of early list items, as suggested
by Bruno et al. [10], then it is possible that studies that ignore
serial position performance and focus exclusively on total list
memorywill find associations between hippocampal size and
memory only when, incidentally, primacy and nonprimacy
outputs are highly correlated. For example, we can imagine
three study participants: participant A recalls all primacy
items (e.g., 4) and all nonprimacy items (e.g., 12) for a total
of 16 items; participant B recalls 0 primacy items, but all non-
primacy items for a total of 12; and participant C recalls all
primacy items, but 0 nonprimacy items for a total of 4. In
this example, and based on our conjecture of a preferential
link between hippocampus and primacy, participant C would
be expected to have a larger hippocampus than participant B
despite a lower total memory score; additionally, participant
Awould be expected to have roughly a similar-sized hippo-
campus as participant C, despite a much higher total score.
This example illustrates how the issues of interstudy vari-
ability in examining the relationship between hippocampal
volume and episodic memory ability may at least partly be
related to differences in serial position effects.
An alternative solution to the issue of inconsistency
across studies may be found in our current results. A look
at Fig. 2 suggests that smaller hippocampal volumes are
only associated with a reduction of memory performance,
specifically delayed primacy, in the presence of high levels
of P tau. Therefore, it may be possible that hippocampal
function, and consequently memory function, is roughly
comparable across a wide range of hippocampal volumes
as long as these remain above a certain size that we can
consider to be “normal.” In contrast, when hippocampal vol-
umes are smaller, they are only good estimators of individual
hippocampal dysfunction, and therefore poorer memory,
when they are also accompanied by a neurodegenerative
process, such as, for example, macrostructural hippocampal
degeneration caused by neurofibrillary tangles. More
research however is required to clarify these issues further.Acknowledgments
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1. Systematic Review: Articles examining the links, in
elderly individuals, between cerebrospinal fluid bio-
markers of Alzheimer’s disease (AD), hippocampal
volume, and memory performance were identified
via reference sections and/or popular search engines.
Our goal was to evaluate the complex relationship
between these variables, keeping in mind recent evi-
dence suggesting that delayed primacy performance
may predict cognitive decline.
2. Interpretation: Our findings suggest that the relation-
ship between hippocampal size and memory perfor-
mance may be understood better if the serial
position in free recall tests is examined and that hip-
pocampal size may play a protective role against the
deleterious effects of P tau on memory.
3. Future directions: Future studies should investigate
whether delayed primacy performance is a sensitive
predictor of conversion to mild cognitive impairment
and/or AD from a cognitively healthy baseline.
Moreover, the relationship between brain structure
and serial position performance in both cognitively
intact and impaired elderly participants should be
elucidated further.References
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